IRIS Accounts Production v24.3.2.46 13939130 director 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh139391302023-03-31139391302024-03-31139391302023-04-012024-03-31139391302022-03-31139391302022-04-012023-03-31139391302023-03-3113939130ns15:EnglandWales2023-04-012024-03-3113939130ns14:PoundSterling2023-04-012024-03-3113939130ns10:Director12023-04-012024-03-3113939130ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3113939130ns10:SmallEntities2023-04-012024-03-3113939130ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3113939130ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3113939130ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3113939130ns10:FullAccounts2023-04-012024-03-3113939130ns10:RegisteredOffice2023-04-012024-03-3113939130ns5:CurrentFinancialInstruments2024-03-3113939130ns5:CurrentFinancialInstruments2023-03-3113939130ns5:ShareCapital2024-03-3113939130ns5:ShareCapital2023-03-3113939130ns5:RetainedEarningsAccumulatedLosses2024-03-3113939130ns5:RetainedEarningsAccumulatedLosses2023-03-3113939130ns5:ComputerEquipment2023-04-012024-03-3113939130ns5:ComputerEquipment2024-03-3113939130ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3113939130ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-31
REGISTERED NUMBER: 13939130 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2024

for

London International Endocrine Clinic
Limited

London International Endocrine Clinic
Limited (Registered number: 13939130)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


London International Endocrine Clinic
Limited

Company Information
for the Year Ended 31 March 2024







DIRECTOR: Professor D Dworakowska





REGISTERED OFFICE: The Mills
Canal Street
Derby
Derbyshire
DE1 2RJ





REGISTERED NUMBER: 13939130 (England and Wales)





ACCOUNTANTS: Bates Weston LLP
Chartered Accountants
The Mills
Canal Street
Derby
DE1 2RJ

London International Endocrine Clinic
Limited (Registered number: 13939130)

Balance Sheet
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,609 -

CURRENT ASSETS
Debtors 5 35,000 1,000
Cash at bank 19,213 -
54,213 1,000
CREDITORS
Amounts falling due within one year 6 13,173 -
NET CURRENT ASSETS 41,040 1,000
TOTAL ASSETS LESS CURRENT
LIABILITIES

43,649

1,000

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 42,649 -
43,649 1,000

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 February 2025 and were signed by:





Professor D Dworakowska - Director


London International Endocrine Clinic
Limited (Registered number: 13939130)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

London International Endocrine Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts receivable for services provided. Turnover is accounted for in the period in which the services are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
Additions 3,913
At 31 March 2024 3,913
DEPRECIATION
Charge for year 1,304
At 31 March 2024 1,304
NET BOOK VALUE
At 31 March 2024 2,609

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed by group undertakings 35,000 -
Other debtors - 1,000
35,000 1,000

London International Endocrine Clinic
Limited (Registered number: 13939130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 11,695 -
Accrued expenses 1,478 -
13,173 -